The story of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of knock-off https://tvsocialnews.com/story7021064/sildenafil-and-big-pharma-a-risky-venture